Rossmax International Ltd. (TPEX:4121)
13.95
-0.20 (-1.41%)
May 29, 2026, 1:30 PM CST
Rossmax International Revenue
Rossmax International had revenue of 938.31M TWD in the quarter ending March 31, 2026, with 1.35% growth. This brings the company's revenue in the last twelve months to 3.81B, down -0.36% year-over-year. In the year 2025, Rossmax International had annual revenue of 3.80B, down -1.34%.
Revenue (ttm)
3.81B
Revenue Growth
-0.36%
P/S Ratio
0.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.80B | -51.80M | -1.34% |
| Dec 31, 2024 | 3.85B | 42.10M | 1.11% |
| Dec 31, 2023 | 3.81B | -535.69M | -12.33% |
| Dec 31, 2022 | 4.34B | 397.05M | 10.06% |
| Dec 31, 2021 | 3.95B | 268.93M | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 2.86B |
| AViTA | 952.73M |
| Bioptik Technology Incorporation | 865.76M |
| Diamond Biotechnology | 501.49M |
| Radiant Innovation | 389.45M |
| Wiltrom | 312.43M |
| Taiwan Biomaterial | 179.17M |
| S&S Healthcare Holding | 178.00M |